Correlation Between NovaBay Pharmaceuticals and Bionano Genomics
Can any of the company-specific risk be diversified away by investing in both NovaBay Pharmaceuticals and Bionano Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NovaBay Pharmaceuticals and Bionano Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NovaBay Pharmaceuticals and Bionano Genomics, you can compare the effects of market volatilities on NovaBay Pharmaceuticals and Bionano Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NovaBay Pharmaceuticals with a short position of Bionano Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NovaBay Pharmaceuticals and Bionano Genomics.
Diversification Opportunities for NovaBay Pharmaceuticals and Bionano Genomics
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between NovaBay and Bionano is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding NovaBay Pharmaceuticals and Bionano Genomics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionano Genomics and NovaBay Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NovaBay Pharmaceuticals are associated (or correlated) with Bionano Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionano Genomics has no effect on the direction of NovaBay Pharmaceuticals i.e., NovaBay Pharmaceuticals and Bionano Genomics go up and down completely randomly.
Pair Corralation between NovaBay Pharmaceuticals and Bionano Genomics
Considering the 90-day investment horizon NovaBay Pharmaceuticals is expected to under-perform the Bionano Genomics. But the stock apears to be less risky and, when comparing its historical volatility, NovaBay Pharmaceuticals is 1.32 times less risky than Bionano Genomics. The stock trades about -0.18 of its potential returns per unit of risk. The Bionano Genomics is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest 29.00 in Bionano Genomics on September 1, 2024 and sell it today you would lose (3.00) from holding Bionano Genomics or give up 10.34% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NovaBay Pharmaceuticals vs. Bionano Genomics
Performance |
| Timeline |
| NovaBay Pharmaceuticals |
| Bionano Genomics |
NovaBay Pharmaceuticals and Bionano Genomics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NovaBay Pharmaceuticals and Bionano Genomics
The main advantage of trading using opposite NovaBay Pharmaceuticals and Bionano Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NovaBay Pharmaceuticals position performs unexpectedly, Bionano Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionano Genomics will offset losses from the drop in Bionano Genomics' long position.| NovaBay Pharmaceuticals vs. Immix Biopharma | NovaBay Pharmaceuticals vs. Cns Pharmaceuticals | NovaBay Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | NovaBay Pharmaceuticals vs. ZyVersa Therapeutics |
| Bionano Genomics vs. Intuitive Surgical | Bionano Genomics vs. Innovative Eyewear | Bionano Genomics vs. Stereotaxis | Bionano Genomics vs. Nexgel Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |